Publications by Dr Steven Masson - ePrints

Browsing publications by Dr Steven Masson.

Newcastle Authors	Title	Year
Professor Stuart McPherson Dr Jess Dyson Dr Laura Jopson Dr Steven Masson Professor Quentin Anstee et al.	How effective are experienced hepatologists at staging fibrosis using non-invasive fibrosis tests in patients with metabolic dysfunction-associated steatotic liver disease?	2024
Professor Stuart McPherson Dr Jess Dyson Dr Steven Masson Professor Quentin Anstee	Letter: Algorithmic NIT approaches to identify advanced liver fibrosis in patients with MASLD: Authors' reply	2024
Professor Stuart McPherson Dr Jess Dyson Dr Laura Jopson Dr Steven Masson Professor Quentin Anstee et al.	Letter: Beyond advanced fibrosis—The critical need for assessing NITs performance in identifying F2-F3 fibrosis. Authors' reply	2024
Dr Steven Masson	Liver transplantation for critically ill patients with acute on chronic liver failure: a prospective national programme of waitlist prioritisation	2024
Dr Steven Masson	Long-term Outcomes from the UK Pilot of Early Liver Transplantation for Severe Alcohol-related Hepatitis	2024
Dr Steven Masson Professor Helen Reeves	Neddylation inhibition prevents acetaminophen-induced liver damage by enhancing the anabolic cardiolipin pathway	2024
Dr Dina Mansour Dr Steven Masson John Hammond Professor Stuart McPherson	British Society of Gastroenterology Best Practice Guidance: outpatient management of cirrhosis - part 1: compensated cirrhosis	2023
Dr Dina Mansour Dr Steven Masson Professor Stuart McPherson	British Society of Gastroenterology Best Practice Guidance: outpatient management of cirrhosis - part 2: decompensated cirrhosis	2023
Dr Dina Mansour Dr Steven Masson John Hammond Professor Stuart McPherson	British Society of Gastroenterology Best Practice Guidance: outpatient management of cirrhosis - part 3: special circumstances	2023
Dr Steven Masson	Deaths from alcohol-related liver disease in the UK: an escalating tragedy	2023
Dr Steven Masson	Extra-hepatic morbidity and mortality in alcohol-related liver disease: Systematic review and meta-analysis	2023
Dr Yusri Taha Dr Steven Masson Professor Stuart McPherson	Impact of 5 years of hepatitis C testing and treatment in the North East of England prisons	2023
Dr Steven Masson	In severe alcohol-related hepatitis, acute kidney injury is prevalent, associated with mortality independent of liver disease severity, and can be predicted using IL-8 and micro-RNAs	2023
Dr Steven Masson	Quality standards for the management of alcohol-related liver disease: Consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology ARLD special interest group	2023
Dr Steven Masson	The Liverpool alcohol-related liver disease algorithm identifies twice as many emergency admissions compared to standard methods when applied to Hospital Episode Statistics for England	2023
Dr Steven Masson Dr Dina Tiniakos	Clinical, histological and molecular profiling of different stages of alcohol-related liver disease	2022
Dr Rebecca Darlay Professor Heather Cordell Professor Ann Daly Professor Chris Day Dr Steven Masson et al.	Corrigendum to: 'A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers' [J Hepatol 2022 (76) 275–282] (Journal of Hepatology (2022) 76(2) (275–282), (S0168827821021115), (10.1016/j.jhep.2021.10.005))	2022
Dr Daniel Geh Robyn Watson Gourab Sen Jeremy French John Hammond et al.	COVID-19 and liver cancer: Lost patients and larger tumours	2022
Dr Yusri Taha Dr Steven Masson Professor Stuart McPherson	Determining the frequency and characteristics of Hepatitis C reinfections in North East England	2022
Professor Helen Reeves Dr Steven Masson	Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy	2022
Dr Steven Masson Misti McCain Professor Helen Reeves	Restoring cellular magnesium balance through Cyclin M4 protects against acetaminophen-induced liver damage	2022
Abdullah Malik Professor Sanjay Pandanaboyana Gourab Sen Professor Stuart McPherson Dr Jess Dyson et al.	Risk factors for decompensation and death following umbilical hernia repair in patients with end-stage liver disease	2022
Dr Steven Masson Professor Derek Manas	A coordinated national UK liver transplant program response, prioritizing waitlist recipients with the highest need, provided excellent outcomes during the first wave of the COVID-19 pandemic	2021
Dr Rebecca Darlay Dr Steven Masson Professor Chris Day Professor Ann Daly Professor Heather Cordell et al.	Genome-wide association study and meta-analysis on alcohol-related liver cirrhosis identifies novel genetic risk factors	2021
Dr Laura Neilson Dr Louise MacDougall Dr Timothy Hardy Dr David Beaton Dr April Phaw et al.	Implementation of a care bundle improves the management of patients with non-alcoholic fatty liver disease	2021
Dr Steven Masson	Liver transplantation for alcohol-related liver disease in the UK: revised UK Liver Advisory Group recommendations for referral	2021
Dr Steven Masson Professor Ann Daly Professor Heather Cordell Professor Chris Day	Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers	2021
Dr Steven Masson	Adult liver transplantation: A UK clinical guideline-part 1: Pre-operation	2020
Dr Steven Masson	Adult liver transplantation: UK clinical guideline-part 2: Surgery and post-operation	2020
Dr Steven Masson	Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study	2020
Dr Steven Masson	The diagnostic and prognostic significance of liver histology in alcoholic hepatitis	2020
Dr Steven Masson	ACG Clinical Guideline for Alcoholic Liver Disease: The MELD Threshold for Corticosteroid Treatment has Yet to be Established	2019
Dr Abdullah Malik Dr Steven Masson Dr Mark Hudson Professor Derek Manas	Impact of Regional Organ Sharing and Allocation in the UK Northern Liver Alliance on Waiting Time to Liver Transplantation and Waitlist Survival	2019
Dr Steven Masson	Natural history of histologically proven alcohol-related liver disease: A systematic review	2019
Dr Sameh Abou-Beih Dr Steven Masson Professor Fiona Oakley Dr Dina Tiniakos	Sinusoidal and pericellular fibrosis in adult post-transplant liver biopsies: association with hepatic stellate cell activation and patient outcome	2019
Dr Dave Houghton Dr Kate Hallsworth Dr Sophie Cassidy Christian Thoma Dr Leah Avery et al.	The degree of hepatic steatosis associates with impaired cardiac and autonomic function	2019
Dr Steven Masson	Top research priorities in liver and gallbladder disorders in the UK	2019
Sebastian Mafeld Dr Steven Masson Aimen Amer Professor Colin Wilson Professor Derek Manas et al.	Treatment of Visceral Transplant Pseudoaneurysms Using Physician-Modified Fenestrated Stent Grafts: Initial Experience	2019
Dr Steven Masson	Application of prognostic scores in the STOPAH trial: Discriminant function is no longer the optimal scoring system in alcoholic hepatitis	2018
Dr Steven Masson Professor Ann Daly Professor Heather Cordell Professor Chris Day	Evaluation of laboratory tests for cirrhosis and for alcohol use, in the context of alcoholic cirrhosis	2018
Dr Steven Masson	Prevalent acute-on-chronic liver failure and response to corticosteroids in alcoholic hepatitis	2018
Dr Steven Masson	Reply to: “The long-term prognosis of alcoholic hepatitis is poor and independent of disease severity for patients surviving an acute episode”	2018
Dr Marie Boyle Dr Steven Masson Professor Quentin Anstee	The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease	2018
Dr Dave Houghton Dr Sophie Cassidy Dr Christian Thoma Dr Kate Hallsworth Dr Leah Avery et al.	Autonomic function is impaired across the spectrum of NAFLD	2017
Dr Dave Houghton Dr Kate Hallsworth Dr Christian Thoma Dr Sophie Cassidy Dr Timothy Hardy et al.	Effects of Exercise on Liver Fat and Metabolism in Alcohol Drinkers	2017
Dr Steven Masson	In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA	2017
Dr Timothy Hardy Dr Mujdat Zeybel Professor Chris Day Dr Christian Dipper Dr Steven Masson et al.	Plasma DNA methylation: A potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease	2017
Dr Paula Iruzubieta Dr Steven Masson Misti McCain Professor Helen Reeves	The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury	2017
Dr Charlotte Johnson Professor Stuart McPherson Dr Steven Masson	An Audit of Primary Prophylaxis Against Variceal Bleeding Amongst Patients with Cirrhosis	2016
Gill O'Neill Dr Steven Masson Professor Ruth McGovern Professor Dorothy Newbury-Birch	Can a theoretical framework help to embed alcohol screening and brief interventions in an endoscopy day-unit?	2016
Dr Sameh Abou-Beih Dr Steven Masson Professor Fiona Oakley Dr Dina Tiniakos	Evaluation of centrilobular fibrosis in post-transplant liver: Preliminary results	2016
Dr Jess Dyson Professor Chris Lamb Dr Steven Masson Dr Mark Hudson Dr Christian Dipper et al.	Implementation of a “care bundle” improves the management of patients admitted to hospital with decompensated cirrhosis	2016
Sarah Welsh Dr Steven Masson Professor Stuart McPherson	Increasing Access to Hepatitis C Treatment in The North East of England	2016
Dr Steven Masson	Portopulmonary Hypertension: Still an Appropriate Consideration for Liver Transplantation?	2016
Dr Sameh Abou-Beih Dr Steven Masson Dr Beate Haugk Professor Fiona Oakley	Sinusoidal and pericellular fibrosis in adult post-transplant liver biopsies: Association with histological changes, hepatic stellate cell activation and impact on patient outcome	2016
Professor Chris Day Dr Steven Masson Professor Ann Daly Professor Heather Cordell	Brief Report: Genetics of Alcoholic Cirrhosis-GenomALC Multinational Study	2015
Dr Mujdat Zeybel Dr Timothy Hardy Stuart Robinson Christopher Fox Professor Quentin Anstee et al.	Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease	2015
Dr Jess Dyson Dr Steven Masson Professor Stuart McPherson Professor Derek Manas Dr Mark Hudson et al.	Experience of Using Advagraf in a Single Liver Transplant Centre in the United Kingdom	2015
Dr Steven Masson	Facilitation of blood donation amongst haemochromatosis patients	2015
Dr Jess Dyson Dr Steven Masson Professor Stuart McPherson Dr Mark Hudson	Impact of a Nurse-Led Annual Review Clinic for Liver Transplant Recipients	2015
Dr Jess Dyson Professor Stuart McPherson Dr Steven Masson Dr Mark Hudson	Importance of Health Education in an Annual Review Liver Transplant Clinic in the United Kingdom	2015
Dr Steven Masson	Liver Transplantation for Portopulmonary Hypertension (PoPH): Multi-centre UK experience over twenty years	2015
Professor Chris Day Dr Steven Masson	Prednisolone or Pentoxifylline for Alcoholic Hepatitis	2015
Michelle Thursby Professor Chris Day Ellen Allison Dr Steven Masson Professor Luke Vale et al.	The clinical effectiveness and cost-effectiveness of STeroids or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2x2 factorial, randomised controlled trial.	2015
Stuart Robinson Dr Steven Masson Dr Mark Hudson Professor Derek Manas	Umbilical hernia repair in cirrhosis: outcomes and prognostic factors in a liver transplant unit	2015
Dr Jess Dyson Dr Mark Hudson Professor Derek Manas Dr Steven Masson	A Positive Complement Dependent Cytotoxic (CDC) Crossmatch Does Not Impact on Patient Survival or Increase the Risk of Acute Cellular Rejection, or Biliary Strictures after Liver Transplantation	2014
Dr Anna Moles Fernandez Dr Lindsay Murphy Dr Caroline Wilson Dr Jayshree Bagchi Chakraborty Christopher Fox et al.	A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse	2014
Dr Steven Masson Dr Stuart Kendrick Dr Ahmed Elsharkawy Dr Mark Hudson	An 'alcohol contract' has no significant effect on return to drinking after liver transplantation for alcoholic liver disease	2014
Dr Steven Masson Ingrid Emmerson Elsbeth Henderson Dr Emma Fletcher Professor Alastair Burt et al.	Clinical but not histological factors predict long-term prognosis in patients with histologically advanced non-decompensated alcoholic liver disease	2014
Dr Mujdat Zeybel Dr Timothy Hardy Christopher Fox Dr Steven Masson Professor Derek Mann et al.	Differential DNA methylation of genes involved in fibrosis progression in NAFLD and ALD	2014
Professor Chris Day Dr Steven Masson	Steroids or Pentoxifylline for Alcoholic Hepatitis: Results of the STOPAH Trial	2014
Steven White Dr Steven Masson	Benefits of a Liver Transplant Outreach Clinic: Increased Referrals and Patient Satisfaction	2013
Professor Quentin Anstee Dr Steven Masson Professor Stuart McPherson	Does the Pre-Bone Mineral Density Frax Score Predict Fracture Risk in Patients with Cirrhosis?	2013
Dr Ahmed Elsharkawy Dr Ulrich Schwab Dr Brendan McCarron Professor Alastair Burt Professor Ann Daly et al.	Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser	2013
Dr Steven Masson	Facilitation of Blood Donation amongst Haemochromatosis Patients: A UK Pilot	2013
Dr James Orr Dr Yvonne Bury Dr Mark Hudson Dr Steven Masson	Liver transplantation for acute liver failure caused by macrophage activation syndrome	2013
Professor Chris Day Dr Steven Masson	Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial	2013
Dr John Brain Dr Steven Masson Professor Alastair Burt	Transplantation for ALD: Lessons from the Explant	2013
Dr Timothy Hardy Dr Christopher Wells Dr Stuart Kendrick Professor Chris Day Professor Alastair Burt et al.	White cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkers	2013
Dr Stuart Kendrick Dr Ahmed Elsharkawy Dr Mark Hudson Dr Steven Masson	An “alcohol contract” has not reduced rates of post-transplant drinking following transplantation for alcoholic liver disease	2012
Dr Eilish Gilvarry Dr Christian Dipper Dr Steven Masson	Benefits of introduction of a symptom triggered regimen for management of alcohol withdrawal in a large teaching hospital trust: reduced admission duration and cost savings	2012
Dr Steven Masson Ingrid Emmerson Professor Alastair Burt Professor Chris Day Dr Stephen Stewart et al.	Clinical but not histological factors predict long-term prognosis in patients with biopsy proven advanced alcoholic liver disease	2012
Dr Steven Masson Ingrid Emmerson Professor Alastair Burt	Clinical but not histological factors predict long-term prognosis in patients with biopsy proven advanced alcoholic liver disease	2012
Dr Ahmed Elsharkawy Professor Stuart McPherson Dr Steven Masson Professor Alastair Burt Dr Mark Hudson et al.	Lesson of the Week: Cholestasis secondary to anabolic steroid use in young men	2012
Dr Mujdat Zeybel Dr Timothy Hardy Frances Wong Professor John Mathers Christopher Fox et al.	Multigenerational epigenetic adaptation of the hepatic wound-healing response	2012
Dr Stuart Kendrick Dr Ahmed Elsharkawy Parimala Saminathan Dr Steven Masson	The effect of an 'alcohol contract' on ethanol consumption after transplantation for alcoholic liver disease	2012
Dr Stuart Kendrick Dr Ahmed Elsharkawy Parimala Saminathan Dr Steven Masson	Transplantation for Alcoholic Liver Disease: Recidivism, Survival and the Effect of an 'Alcohol Contract'	2012
Dr Steven Masson Dr John Rose Dr Christopher Record	Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: A decade of experience	2008
Dr Steven Masson Dr David Chinn	Is anaemia relevant in the referral and diagnosis of colorectal cancer?	2007
Dr Steven Masson Dr John Rose Dr Christopher Record	Minimal hepatic encephalopathy after tips insertion is associated with a reduced quality of life	2007
Dr Steven Masson Dr John Rose Dr Christopher Record	Covered stent grafts for tips insertion provide improved clinical outcome: A decade of experience	2006
Dr Steven Masson Dr Stephen Bourke Dr Graham Burns	Interstitial pneumonitis after infliximab therapy for Crohn's disease	2006
Dr Steven Masson Dr John Mansfield	How important is onset of action in ulcerative colitis therapy?	2005
Dr Steven Masson	Potential of hematopoietic stem cell therapy in hepatology: A critical review	2004
Dr Steven Masson	Serum from patients with fulminant hepatic failure causes hepatocyte detachment and apoptosis by a beta(1)-integrin pathway	2004